Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

LEADING BUILD TO RENT OPERATOR LAUNCHES SECTOR-FIRST PRESCRIPTION SERVICE WITH NATIONAL PHARMACY CHAIN

February 23, 2023 Business Services

Moda Living, the UK’s leading developer and operator of rental communities, has today announced a partnership with VideoGP by LloydsPharmacy, …
News
Press release

Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics

February 23, 2023 Business Services

Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research …
News
Press release

8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline

February 23, 2023 Business Services

LONDON 23rd February 2023 
News
Press release

OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology

February 22, 2023 Business Services

Nantes, France – February 22, 2023, 6:00 p.m.
News
Press release

ViiV Healthcare receives EU Marketing Authorisation for Triumeq PD, the first dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV in Europe

February 22, 2023 Business Services

  
News
Press release

PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA

February 22, 2023 Business Services

BASILDON, UK, 22 February 2023   Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already …
News
Press release

Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter

February 22, 2023 Business Services

London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights …
News
Press release

NICE Publishes Reimbursement Recommendation for Translarna™

February 22, 2023 Business Services

London, UK, 22nd February, 2023 — PTC Therapeutics, Ltd. today announced the National Institute for Health and Care Excellence (NICE) has published …
News
Press release

Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences

February 22, 2023 Business Services

Princeton, United States / Bengaluru, India, February 21, 2023: Indegene, a digital-first, life sciences commercialization company today announced the launch …
News
Press release

Modus Therapeutics announces positive topline data from its Phase 1b LPS provocation study evaluating the potential of sevuparin for treatment of sepsis

February 22, 2023 Business Services

STOCKHOLM, SWEDEN – 21 February 2023: Modus Therapeutics AB (“Modus”), a company developing innovative treatments for patients with major unmet …
News
Press release

Beckley Psytech receives FDA Investigational New Drug (IND) approval for Phase IIb study of BPL-003, a novel synthetic formulation of 5-MeO-DMT (Mebufotenin)

February 21, 2023 Business Services

Oxford, United Kingdom – 21 FEBRUARY 2023 – Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric …
News
Press release

AstraZeneca and MSD present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium

February 20, 2023 Business Services

Results from the final prespecified overall survival (OS) analysis of the PROpel Phase III trial in metastatic castration-resistant prostate cancer …
News
Press release

SMC recommends Opdivo® (nivolumab) for use post-surgery in specific urothelial cancer patients

February 20, 2023 Business Services

(Uxbridge, Middlesex, 13 February 2023) – The Scottish Medicines Consortium (SMC) has accepted Bristol Myers Squibb’s (BMS’) nivolumab for the …
News
Press release

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

February 20, 2023 Business Services

PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …
Feature
Case study

Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in Patients with BRCA-Positive Metastatic CastrationResistant Prostate Cance

February 20, 2023 Business Services

BEERSE, BELGIUM, 16 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025